You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 204651 - 204660 of 207725 results
  1. MAJOR RESEARCH FINDINGS OFTEN QUICKLY FOLLOW THE INVENTION AND DEVELOPMENT OF A NEW OR BETTER METHOD OF MEASURING SOMETHING, THEREBY CONTRIBUTING TO SCIENCE AND INDUSTRY.

    SBC: Illiana Aviation Sciences Ltd            Topic: N/A

    MAJOR RESEARCH FINDINGS OFTEN QUICKLY FOLLOW THE INVENTION AND DEVELOPMENT OF A NEW OR BETTER METHOD OF MEASURING SOMETHING, THEREBY CONTRIBUTING TO SCIENCE AND INDUSTRY. HENNESSY'S DEVELOPMENT OF THE LASER OPTOMETER IN 1970 LED TO AN EXPLOSION OF RESEARCH FINDINGS THAT SUBSTANTIALLY REVISED OUR CENTURY-OLD CONCEPTION OF THE VISUAL ACCOMMODATION PROCESS AND ITS FUNCTIONAL SIGNIFICANCE. LASER OPTOM ...

    SBIR Phase I 1985 Department of Health and Human Services
  2. AN ADVERSE REACTION TO A DRUG WHICH TAKES PLACE WHILE A PATIENT IS ON MEDICATION IS OFTEN IMPOSSIBLE TO DIAGNOSE ACCURATELY.

    SBC: Imbic Corpon            Topic: N/A

    AN ADVERSE REACTION TO A DRUG WHICH TAKES PLACE WHILE A PATIENT IS ON MEDICATION IS OFTEN IMPOSSIBLE TO DIAGNOSE ACCURATELY. THE NATURE OF THE UNDERLYING REACTION MAY HAVE AN IMMUNOLOGIC, TOXICOLOGIC, OR PHARMACOLOGIC BASIS. AMONG THE MOST NOTABLE IMMUNOLOGIC REACTIONS TO DRUGS ARE THOSE WHICH GIVE RISE TO ANTIBODIES THAT, IN THE PRESENCE OF DRUG, ATTACH TO BLOOD CELLS AND DESTROY THEM. THE MOST C ...

    SBIR Phase I 1985 Department of Health and Human Services
  3. BETA-ENDORPHIN (BE) IS A PEPTIDE COMPOSED OF THE 30 CARBOXYL-TERMINAL RESIDUES OF BETA-LIPOTROPIN (BLPH).

    SBC: Imbic Corpon            Topic: N/A

    BETA-ENDORPHIN (BE) IS A PEPTIDE COMPOSED OF THE 30 CARBOXYL-TERMINAL RESIDUES OF BETA-LIPOTROPIN (BLPH). IT HAS BEEN SHOWN TO BE A NATURALLY OCCURRING OPIATE, AS WELL AS TO POSSESS NONOPIATE RELATED BIOACTIVITY. CURRENT ASSAY TECHNIQUES ARE INADEQUATE DUE TO LACK OF IMMUNOLOGICAL SPECIFICITY RESULTING FROM CROSS-REACTING OF BE AND BLPH WITH THE SAME ANTIBODIES. A SEPARATION METHOD UTILIZING THE S ...

    SBIR Phase I 1985 Department of Health and Human Services
  4. THE FORMATION OF DNA-CARCINOGEN ADDUCTS IS AN IMPORTANT ENVIRONMENTAL FACTOR IN CARCINOGENESIS.

    SBC: Imbic Corpon            Topic: N/A

    THE FORMATION OF DNA-CARCINOGEN ADDUCTS IS AN IMPORTANT ENVIRONMENTAL FACTOR IN CARCINOGENESIS. RECENT TECHNIQUES FOR ISOLATION AND CHARACTERIZATION OF DEOXYNUCLEOSIDE-CARCINOGEN ADDUCTS AND SUBSEQUENT IMMUNOASSAY PROCEDURES CAN EFFECTIVELY DETECT THESE ADDUCTS FROM CELL LYSATES IN THE RANGE OF 1 ADDUCT/107 BASES. WE WILL USE OUR COMBINED TECHNICAL EXPERTISE IN THE AREAS OF NUCLEOTIDE/NUCLEOSIDE C ...

    SBIR Phase I 1985 Department of Health and Human Services
  5. NEEDED FIBER OPTICS FOR ENDOSCOPIC CO(2) LASER SURGERY

    SBC: Imet Corp.            Topic: N/A

    THIS PROPOSAL IS FOR THE DEVELOPMENT OF FLEXIBLE SILVER HALIDE OPTICAL FIBERS TO TRANSMIT INFRARED RADIATION OF 10.6 MICRONS FROM A CO(2) LASER WITHOUT APPRECIABLE LOSS OF POWER. PHASE I OF THE PROPOSAL IS FOR THE INVESTIGATION OF A NUMBER OF NOVEL PROCEDURES FOR THE PURIFICATION OF THE SILVER HALIDES AND FOR THE FABRICATION OF OPTICAL FIBERS FROM THIS MATERIAL.

    SBIR Phase II 1985 Department of Health and Human Services
  6. RESEARCH ON NOVEL SOFT X-RAY DETECTORS DERIVED ROM IONOMET'SEXPERIENCE IN LITHOGRAPHY AND PARTICLE DETECTION ARE HEREIN PROPOSED IN ANSWER TO THE EMPHATIC NEED FOR SIGNIFICANT GAINS IN THE DETECTIVITY AND SIGNAL TO NOISE RATIO OF AVAILABLE SOFT

    SBC: Imet Corp.            Topic: N/A

    RESEARCH ON NOVEL SOFT X-RAY DETECTORS DERIVED ROM IONOMET'SEXPERIENCE IN LITHOGRAPHY AND PARTICLE DETECTION ARE HEREIN PROPOSED IN ANSWER TO THE EMPHATIC NEED FOR SIGNIFICANT GAINS IN THE DETECTIVITY AND SIGNAL TO NOISE RATIO OF AVAILABLE SOFT X-RAY-SENSITIVE MATERIALS. IMPROVED INSIGHT (OVER THE ELECTRON MICROSCOPE) INTO LIVING AND MANMADE MICROSTRUCTURES IS IMPLICIT DUE TO THE SELECTIVE HIGH AB ...

    SBIR Phase I 1985 National Science Foundation
  7. IMI-TECH CORPORATION PROPOSES TO DETERMINE THE FEASIBILITY OF MEETING THE NAVY'S NEED FOR A POURED-IN-PLACE, LIGHTWEIGHT FLOTATION FOAM THAT WILL NOT SUSTAIN COMBUSTION, DOES NOT RELEASE HAZARDOUS AMOUNTS OF TOXIC GASES WHEN EXPOSED TO FLAMES, AND HAS

    SBC: Imi-tech Corp            Topic: N/A

    IMI-TECH CORPORATION PROPOSES TO DETERMINE THE FEASIBILITY OF MEETING THE NAVY'S NEED FOR A POURED-IN-PLACE, LIGHTWEIGHT FLOTATION FOAM THAT WILL NOT SUSTAIN COMBUSTION, DOES NOT RELEASE HAZARDOUS AMOUNTS OF TOXIC GASES WHEN EXPOSED TO FLAMES, AND HAS LOW WATER ABSORPTION. THE TECHNOLOGY TO MEET THIS REQUIREMENT, WITHOUT THE USE OF TOXIC GAS-PRODUCING FLAME RETARDANTS, EXISTS AT IMI-TECH TODAY. TH ...

    SBIR Phase I 1985 Department of DefenseNavy
  8. FEASIBILITY STUDIES FOR DEVELOPING A NOVEL CLINICAL DEVICE ARE PROPOSED.

    SBC: Immunicon Corporation            Topic: N/A

    FEASIBILITY STUDIES FOR DEVELOPING A NOVEL CLINICAL DEVICE ARE PROPOSED. THIS DEVICE WHICH WOULD USE IMMUNOLOGICAL AND COMPLEMENT REAGENTS IN CONJUNCTION WITH FILTRATION AND/OR ONE OR MORE MAGNETIC RETRIEVAL SYSTEMS TO PRODUCE A NEW SEPARATION AND COLLECTION TECHNOLOGY COULD RESULT IN TOTALLY NEW MODALITIES OF TREATMENT FOR NUMEROUS DISEASE STATES WHICH CURRENTLY ARE CLASSIFIED AS UNTREATABLE. THI ...

    SBIR Phase I 1985 Department of Health and Human Services
  9. THE OBJECT OF THIS PROJECT IS TO PRODUCE A KIT THAT UTILIZES ANTI-CSAP MONOCLONAL ANTIBODIES (MABS) FOR CLINICAL RADIOIMMUNODETECTION (RAID) OF COLORECTAL AND PANCREATIC CANCERS.

    SBC: IMMUNOMEDICS, INC.            Topic: N/A

    THE OBJECT OF THIS PROJECT IS TO PRODUCE A KIT THAT UTILIZES ANTI-CSAP MONOCLONAL ANTIBODIES (MABS) FOR CLINICAL RADIOIMMUNODETECTION (RAID) OF COLORECTAL AND PANCREATIC CANCERS. PHASE I WILL BE DEVOTED TO SELECTION OF HYBRIDOMAS WITH SPECIFICITY TO CSAP, AND MABS THAT ARE SUITABLE FOR IMAGING. IT WILL BE ACHIEVED BY INVESTIGATING THEIR IN VIVO DISTRIBUTION IN TUMOR AND NONTUMOR TISSUES USING AN A ...

    SBIR Phase I 1985 Department of Health and Human Services
  10. THIS PROJECT WILL EVALUATE ANTIBODY-MEDIATED, POLYMER-BOUND YTTRIUM-90 AS A CANCER THERAPY AGENT.

    SBC: IMMUNOMEDICS, INC.            Topic: N/A

    THIS PROJECT WILL EVALUATE ANTIBODY-MEDIATED, POLYMER-BOUND YTTRIUM-90 AS A CANCER THERAPY AGENT. ANTIBODIES WILL BE COUPLED THROUGH ONE COVALENT BOND TO A SMALL POLYLYSINE UNIT. THE LATTER WILL CARRY, VIA A BIFUNCTIONAL COUPLING AGENT, MOLECULES OF THE TRIVALENT METAL CHELATING SIDEROPHORE, DEFEROXAMINE. EACH DEFEROXAMINE WILL BE COMPLEXED WITH A SINGLE ATOM OF YTTRIUM-90, A HIGH ENERGY BETA-EMIT ...

    SBIR Phase I 1985 Department of Health and Human Services
US Flag An Official Website of the United States Government